UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Viruses in cancer treatment

Clinical & translational oncology, 2013-03, Vol.15 (3), p.182-188

Alemany, R.

2013

Volltextzugriff (PDF)

Recent advances in cancer therapy: an overview

Current pharmaceutical design, 2010-01, Vol.16 (1), p.3-10

2010

Volltextzugriff (PDF)

Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial

Trials, 2021-05, Vol.22 (1), p.356-356, Article 356

2021

Volltextzugriff (PDF)

Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol

BMC urology, 2021-01, Vol.21 (1), p.12-12, Article 12

2021

Volltextzugriff (PDF)

iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy

Gene therapy, 2014-08, Vol.21 (8), p.767-774

2014

Volltextzugriff (PDF)

Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment

Gene therapy, 2017-02, Vol.24 (2), p.92-103

2017

Volltextzugriff (PDF)

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

Cancer Immunology, Immunotherapy, 2024-01, Vol.73 (1), p.5-5, Article 5

2024

Volltextzugriff (PDF)

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

JNCI : Journal of the National Cancer Institute, 2003-05, Vol.95 (9), p.652-660

2003

Volltextzugriff (PDF)

Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

Stem Cells International, 2017-01, Vol.2017 (2017), p.1-10-79

2017

Volltextzugriff (PDF)

Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction

Cancer gene therapy, 2016-12, Vol.23 (12), p.411-414

2016

Volltextzugriff (PDF)

Blood clearance rates of adenovirus type 5 in mice

Journal of general virology, 2000-11, Vol.81 (11), p.2605-2609

2000

Volltextzugriff (PDF)

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

Gene therapy, 2001-09, Vol.8 (17), p.1347-1353

2001

Volltextzugriff (PDF)

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study

Cancer gene therapy, 2010-07, Vol.17 (7), p.476-483

2010

Volltextzugriff (PDF)

GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution

Gene therapy, 2012-11, Vol.19 (11), p.1048-1057

2012

Volltextzugriff (PDF)

First results of running the LHC with lead ions at a beam energy of 6.8 Z TeV

Journal of physics. Conference series, 2024-01, Vol.2687 (2), p.22001

2024

Volltextzugriff (PDF)

Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD

Gene therapy, 2012-04, Vol.19 (4), p.453-457

2012

Volltextzugriff (PDF)

First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer

European journal of cancer (1990), 2016-12, Vol.69, p.S99-S100

2016

Volltextzugriff (PDF)

Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity

Gene therapy, 2015-07, Vol.22 (7), p.596-601

2015

Volltextzugriff (PDF)

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses

Gene therapy, 2009-12, Vol.16 (12), p.1441-1451

2009

Volltextzugriff (PDF)

Structure-effect relation of C18 long-chain fatty acids in the reduction of body weight in rats

International Journal of Obesity, 2008-03, Vol.32 (3), p.464-473

2008

Volltextzugriff (PDF)

Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies

Cancer gene therapy, 2010-11, Vol.17 (11), p.792-802

2010

Volltextzugriff (PDF)

The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model

Cancer gene therapy, 2014-02, Vol.21 (2), p.68-73

2014

Volltextzugriff (PDF)

665: Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas

European journal of cancer (1990), 2014-07, Vol.50, p.S159-S159

2014

Volltextzugriff (PDF)

661: Wnt/β-catenin signalling inhibition decreases cell proliferation in Wnt autocrine-soft tissue sarcoma cells

European journal of cancer (1990), 2014-07, Vol.50, p.S158-S158

2014

Volltextzugriff (PDF)

Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity

Cancer gene therapy, 2009-03, Vol.16 (3), p.256-265

2009

Volltextzugriff (PDF)

1 – 25 von 1.616

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.382)
Mit Volltextzugriff
(1.432)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.433)
Spanisch
(169)
Französisch
(12)
Portugiesisch
(11)
Deutsch
(11)
Japanisch
(2)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Viruses in cancer treatment

Recent advances in cancer therapy: an overview

Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial

Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol

iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy

Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction

Blood clearance rates of adenovirus type 5 in mice

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study

GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution

First results of running the LHC with lead ions at a beam energy of 6.8 Z TeV

Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD

First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer

Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses

Structure-effect relation of C18 long-chain fatty acids in the reduction of body weight in rats

Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies

The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model

665: Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas

661: Wnt/β-catenin signalling inhibition decreases cell proliferation in Wnt autocrine-soft tissue sarcoma cells

Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity

Suchergebnisse filtern